Cargando…
POSA279 The Impact of the COVID-19 Pandemic on the MHRA’s Early Access to Medicines Scheme
Autores principales: | Ruane, P, Brown, R, Francis, LE, Sam, L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769624/ http://dx.doi.org/10.1016/j.jval.2021.11.846 |
Ejemplares similares
-
Concerns raised with MHRA of anticoagulant use during pandemic
Publicado: (2020) -
UK's MHRA publishes guidance for valproate PPP during pandemic
Publicado: (2020) -
Valproate MHRA Guidance: Limitations and Opportunities
por: Watkins, Lance, et al.
Publicado: (2019) -
The MHRA pharmacovigilance inspection programme: priorities and
challenges
por: Adams, Anna L, et al.
Publicado: (2019) -
MHRA COVID-19 website for reporting ADRs and incidents
Publicado: (2020)